Chlamydia pneumoniae The Lung and the Heart
Chlamydia pneumoniae is now recognized as an important human pathogen. Chlamydia pneumoniae is involved in 5%-15% of community acquired pneumonias, and recent data indicate its relevance in severe pneumonia and as a respiratory pathogen in immunocompromised subjects. A causal role for Chlamydia pneu...
| Main Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Milano
Springer Milan
1999, 1999
|
| Edition: | 1st ed. 1999 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- History of Chlamydia pneumoniae (TWAR)
- Chlamydia pneumoniae: Culture Methods
- Serology for Chlamydia pneumoniae (TWAR)
- Chlamydia pneumoniae: Molecular Biology Methods
- Chlamydia pneumoniae Infections: Applications of Laboratory Methods
- Chlamydia pneumoniae: How to Document Respiratory Infection
- Chlamydia pneumoniae: Epidemiology
- Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatment
- Chlamydia pneumoniae: Clinical Characteristics of Acute Respiratory Infections
- Are Atypical Pathogens Important for Patients with Community-Acquired Pneumonia?
- Immunology of Chlamydia pneumoniae
- Chronic Chlamydia pneumoniae Infections
- Chlamydia pneumoniae: A New Possible Cause of Asthma
- Chlamydia pneumoniae: An Important Pathogen in Chronic Bronchitis
- Chlamydia pneumoniae: A New Threat for HIV-infected Subjects
- Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factor
- Chlamydia pneumoniae and Atherosclerosis: Mechanisms of Vascular Damage
- Chlamydia pneumoniae and Atherosclerosis: Animal Models
- Open and Controlled Intervention Trials for “Unusual” Anti-Chlamydia pneumoniae Indications: Asthma, Atherosclerosis, Myocardial Infarction
- Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Disease
- Antibiotic Treatment in Atherosclerosis and Myocardial Infarction
- A Controlled Intervention Study with Antibiotics in Symptomatic Coronary Patients Irrespective of Serology
- Open-Label Before-After Trials of Anti-Chlamydia pneumoniae Antibiotics in Asthma
- Treatment of Chronic Infection with Chlamydia pneumoniae in Asthma
- Chlamydia pneumoniae Infections in Children
- Perspectives and Perceptions on the Clinical Relevance ofChlamydia pneumoniae Infection